ArticleChronic diseases and translational medicine2024

Adaptive ultra-hypofractionated whole-pelvic radiotherapy in high-risk and very high-risk prostate cancer on 1.5-Tesla MR-Linac: Estimated delivered dose and early toxicity results.

Linrui Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.